Carson Wealth (CWM LLC)
ATRA icon

Carson Wealth (CWM LLC)’s Atara Biotherapeutics ATRA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-542
Closed -$5K – 4815
2024
Q2 		$5K Sell
542
-256
-32% -$3.85K ﹤0.01% 3839
2024
Q1 		$14K Buy
798
+248
+45% +$4.4K ﹤0.01% 3121
2023
Q4 		$7K Buy
550
+521
+1,797% +$12.1K ﹤0.01% 3326
2023
Q3 		$1K Buy
29
+24
+480% +$1.07K ﹤0.01% 3921
2023
Q2 		$0 Hold
5
– – ﹤0.01% 4167
2023
Q1 		$0 Sell
5
-23
-82% -$2.23K ﹤0.01% 4035
2022
Q4 		$2K Sell
28
-16
-36% -$1.67K ﹤0.01% 3499
2022
Q3 		$4K Buy
+44
New +$4.94K ﹤0.01% 3133
2022
Q2 		– Sell
-4
Closed -$1K – 3767
2022
Q1 		$1K Buy
+4
New +$1.27K ﹤0.01% 3293

Other funds holding ATRA

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Carson Wealth (CWM LLC)'s ATRA Position: Q3 2024 in Review

Carson Wealth (CWM LLC) sold out of Atara Biotherapeutics (ATRA) in Q3 2024, closing a stake of 542 shares — an estimated $5K sold.

Carson Wealth (CWM LLC) first reported a position in ATRA in Q1 2022 and held it in 9 quarters. The position peaked at $14K in Q1 2024. 35 funds tracked by Wall St. Rank hold ATRA as of Q3 2024.

  • Carson Wealth (CWM LLC) reported no remaining Atara Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 542 Atara Biotherapeutics shares in Q3 2024, an estimated $5K.
  • Carson Wealth (CWM LLC) first reported a position in Atara Biotherapeutics in Q1 2022 and held it in 9 quarters.
  • Carson Wealth (CWM LLC)'s Atara Biotherapeutics position peaked at $14K in Q1 2024.
  • 35 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2024.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2024, filed 8 Oct 2024.